Nuñez-Figueredo Yanier, Ramirez-Sanchez Jeney, Issac Yeniceis Alcantara, Ochoa-Rodriguez Estael, Verdecia-Reyes Yamila, Delgado-Hernandez Rene, Souza Diogo O, Andreu Gilberto L Pardo
Centro de Investigación y Desarrollo de Medicamentos, Ciudad Habana, Cuba.
Laboratorio de Síntesis Orgánica de La Facultad de Química de La Universidad de La Habana Ciudad de la Habana, Cuba.
Drug Res (Stuttg). 2018 May;68(5):263-269. doi: 10.1055/s-0043-121220. Epub 2017 Nov 3.
Free radicals are important mediators in a number of neurodegenerative diseases and molecules capable of scavenging reactive oxygen species (ROS) may be a feasible strategy for protecting neuronal cells. In this sense, polyphenols have been studied for their antioxidant effects, KM-34 (5-(3, 4-dydroxyl-benzylidene)-2, 2-dimethyl-1, 3-dioxane-4, 6-Dione) is a novel synthetic catechol with potential neuroprotective and antioxidant properties. We have assessed the antioxidant (as scavenging and iron-chelating compound) and neuroprotectant in vitro (in PC12 cell injury induced by HO, glutamate or FeSO/AA) of KM-34. KM-34 was found to be a potent antioxidant, as shown by (i) inhibition of iron induced-brain lipid peroxidation, (ii) inhibition of 2-deoxyribose degradation, (iii) inhibition of superoxide radicals generation (IC=11.04 μM) and (iv) inhibition of 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical reduction (IC=16.26 μM). The overall anti-oxidant action of KM-34 appears to be a combination of a direct reaction with free radicals and chelating the metal ions responsible for the production of ROS. Our work suggests that the antioxidant properties of KM-34 may provide future therapeutic approaches for neurodegenerative disorders.